# Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V

> **NCT03565913** · PHASE2,PHASE3 · ACTIVE_NOT_RECRUITING · sponsor: **University of Texas Southwestern Medical Center** · enrollment: 269 (actual)

## Conditions studied

- CKD Stage 5

## Interventions

- **DRUG:** EffCaMgCit
- **OTHER:** CaAcS

## Key facts

- **NCT ID:** NCT03565913
- **Lead sponsor:** University of Texas Southwestern Medical Center
- **Sponsor class:** OTHER
- **Phase:** PHASE2,PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** ACTIVE_NOT_RECRUITING
- **Start date:** 2017-01-22
- **Primary completion:** 2025-12-31
- **Final completion:** 2025-12-31
- **Target enrollment:** 269 (ACTUAL)
- **Last updated:** 2025-05-11


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03565913

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03565913, "Potential Therapeutic Role of Effervescent Calcium-Magnesium Citrate in Chronic Kidney Disease Stage V". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT03565913. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*